{
    "code": "02025434",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025434",
    "time": "2017-04-07 03:04:16",
    "許可證字號": "衛署藥輸字第025434號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/06\/14",
    "發證日期": "100\/06\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202543401",
    "中文品名": "福退癌膜衣錠400毫克",
    "英文品名": "Votrient (Pazopanib HCl) film-coated tablets 400mg",
    "適應症": "晚期腎細胞癌之第一線治療，或用於已接受過細胞激素(CYTOKINE)治療失敗之晚期腎細胞癌患者。\r\nVotrient 適用於治療先前曾接受化療的晚期軟組織肉瘤(STS)患者。使用限制: Votrient 對於脂肪細胞型(adipocytic) STS或胃腸道基質瘤(gastrointestinal stromal tumor)的療效尚未獲得證實。",
    "劑型": "116膜衣錠",
    "包裝": "4-1000錠塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "PAZOPANIBHYDROCHLORIDE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F130044400  GLAXO OPERATIONS UK LIMITED",
        "製造廠廠址": "PRIORY STREET, WARE, HERTFORDSHIRE, SG12 0DJ, UNITED KINGDOM.",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F410122000  GLAXO WELLCOME, S.A.",
            "製造廠廠址": "AVENIDA EXTREMADURA 3, ARANDA DE DUERO, BURGOS 09400, SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": "包裝及分裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013003000",
            "成分名稱": "PAZOPANIB HYDROCHLORIDE",
            "含量描述": "(Eq. to Pazopanib....400mg)",
            "含量": "433.4000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "福退癌膜衣錠-TWI-251116-回一校-106-03-21.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025434&Seq=014&Type=9"
        },
        {
            "title": "020254340009___20111018.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025434&Seq=003&Type=8"
        }
    ]
}